Search for: "VERINATA HEALTH, INC. v. ARIOSA DIAGNOSTICS, INC. "
Results 1 - 15
of 15
Sort by Relevance
|
Sort by Date
25 Oct 2023, 10:24 am
Verinata Health, Inc., 805 F.3d 1359, 1367 (Fed. [read post]
24 Mar 2021, 2:32 pm
Ariosa Diagnostics v. [read post]
12 May 2020, 8:56 am
” Ariosa Diagnostics v. [read post]
26 Apr 2020, 12:16 am
See Verinata Health, Inc. v. [read post]
9 Feb 2020, 3:05 pm
Ariosa Diagnostics v. [read post]
16 Jul 2019, 1:54 am
Sequenom were denied permission to appeal to the US Supreme Court (Sequenom v Ariosa Diagnostics, Inc 136 S.Ct. 2511 (2016)).In an attempt to introduce a similar issue into the UK case, TDL argued that the patent related to a discovery, and was therefore excluded from patentability under Section 1(2)(a) UKPA 1977. [read post]
27 Feb 2019, 6:00 am
In Verinata Health, Inc. v. [read post]
8 Jan 2018, 7:13 am
" Verinata Health, Inc., et. al. v. [read post]
23 Jan 2017, 7:44 am
" Verinata Health, Inc., et al v. [read post]
23 Jan 2017, 7:43 am
" Verinata Health, Inc., et al v. [read post]
22 Dec 2016, 7:58 pm
”Ariosa Diagnostics v. [read post]
9 Aug 2016, 12:06 pm
” Ariosa Diagnostics v. [read post]
7 Dec 2015, 9:59 pm
By Donald Zuhn -- Last month, in Ariosa Diagnostics v. [read post]
16 Nov 2015, 5:31 pm
In ARIOSA DIAGNOSTICS v, VERINATA HEALTH, INC., the IPR petitioner-appellant ARIOSA DIAGNOSTICS convinced the CAFC to vacate a decision of PTAB, costing the patentee a finding of nonobviousness:For the foregoing reasons, we vacate the Board’s find-ing of nonobviousness and remand.The issue is "how much" consideration PTAB placed on Exhibit 1010:Here, we cannot confidently discern whether the Board, in its… [read post]
26 Aug 2013, 8:52 am
” Rader cited Pfizer, Inc. v. [read post]